(Reuters) - The U.S. Food and Drug Administration approved GE HealthCare's diagnostic drug for use in detection of coronary ...
Selvan Senthivel is the new chief technology officer for the 6-year-old Seattle startup. Senthivel was most recently CTO for ...
GE HealthCare Technologies (GEHC) is lower before the open, after a bear note from UBS pointed towards several risks ...
GE HealthCare (GEHC) was cut to sell by UBS on Thursday, with the bank asserting that risks such as increasing Chinese ...
GE HealthCare announces FDA approval of Flyrcado (flurpiridaz F 18) injection PET radiotracer for enhanced diagnosis of ...
The deal to acquire MIM Software earlier this year is bearing fruit for the Chicago-based medical device company, which sees ...
GE HealthCare Technologies has shown promising performance, with a 12% stock increase since June. Read why I continue to rate ...
Micron stock surges after strong earnings and guidance, fellow chip makers such as Nvidia and ASML rally, Southwest Airlines ...
GE HealthCare’s recently acquired MIM Software division has secured an FDA clearance for a tool to help quantify the density ...
The GE HealthCare imaging tool is coming out as pharma companies release new therapies onto the market to help treat the ...
GE HealthCare (Nasdaq: GEHC) today announced its latest innovations in radiation oncology that will be showcased at the ...